Page last updated: 2024-11-02

pirenzepine and Gastric Diseases

pirenzepine has been researched along with Gastric Diseases in 3 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vakhrushev, IaM1
Loshchakova, OIu1
Daniotti, S1
Del Soldato, P1
Okajima, K1
Murakami, K1
Liu, W1
Uchiba, M1

Other Studies

3 other studies available for pirenzepine and Gastric Diseases

ArticleYear
[Experience of treatment of patients with gastropathy induced by non-steroid anti-inflammatory drugs].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2007, Issue:1

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Biomarkers; Drug Therapy, Combinat

2007
Comparative studies of the effects of some antimuscarinic agents on gastric damage and pupillary reflex in the rat.
    British journal of pharmacology, 1984, Volume: 82, Issue:2

    Topics: Animals; Atropine; Benzodiazepinones; Female; N-Methylscopolamine; Oxotremorine; Parasympatholytics;

1984
Inhibition of neutrophil activation by ranitidine contributes to prevent stress-induced gastric mucosal injury in rats.
    Critical care medicine, 2000, Volume: 28, Issue:8

    Topics: Animals; Calcium; Cells, Cultured; E-Selectin; Endothelium, Vascular; Gastric Mucosa; Histamine H2 A

2000